Futaki M - Search Results

1

Engraftment of hematopoietic progenitor cells transduced with the Fanconi anemia group C gene (FANCC).

Liu JM, Kim S, Read EJ, Futaki M, Dokal I, Carter CS, Leitman SF, Pensiero M, Young NS, Walsh CE. Liu JM, et al. Among authors: futaki m. Hum Gene Ther. 1999 Sep 20;10(14):2337-46. doi: 10.1089/10430349950016988. Hum Gene Ther. 1999. PMID: 10515453 Clinical Trial.

2

The FANCG Fanconi anemia protein interacts with CYP2E1: possible role in protection against oxidative DNA damage.

Futaki M, Igarashi T, Watanabe S, Kajigaya S, Tatsuguchi A, Wang J, Liu JM. Futaki M, et al. Carcinogenesis. 2002 Jan;23(1):67-72. doi: 10.1093/carcin/23.1.67. Carcinogenesis. 2002. PMID: 11756225

3

Fanconi anemia protein, FANCG, is a phosphoprotein and is upregulated with FANCA after TNF-alpha treatment.

Futaki M, Watanabe S, Kajigaya S, Liu JM. Futaki M, et al. Biochem Biophys Res Commun. 2001 Feb 23;281(2):347-51. doi: 10.1006/bbrc.2001.4359. Biochem Biophys Res Commun. 2001. PMID: 11181053

4

Chromosomal breakage syndromes and the BRCA1 genome surveillance complex.

Futaki M, Liu JM. Futaki M, et al. Trends Mol Med. 2001 Dec;7(12):560-5. doi: 10.1016/s1471-4914(01)02178-5. Trends Mol Med. 2001. PMID: 11733219

5

The IVS4 + 4 A to T mutation of the fanconi anemia gene FANCC is not associated with a severe phenotype in Japanese patients.

Futaki M, Yamashita T, Yagasaki H, Toda T, Yabe M, Kato S, Asano S, Nakahata T. Futaki M, et al. Blood. 2000 Feb 15;95(4):1493-8. Blood. 2000. PMID: 10666230 Free article.

6

A cytoplasmic serine protein kinase binds and may regulate the Fanconi anemia protein FANCA.

Yagasaki H, Adachi D, Oda T, Garcia-Higuera I, Tetteh N, D'Andrea AD, Futaki M, Asano S, Yamashita T. Yagasaki H, et al. Among authors: futaki m. Blood. 2001 Dec 15;98(13):3650-7. doi: 10.1182/blood.v98.13.3650. Blood. 2001. PMID: 11739169 Free article.

7

A possible correlation between the type of bcr-abl hybrid messenger RNA and platelet count in Philadelphia-positive chronic myelogenous leukemia.

Inokuchi K, Inoue T, Tojo A, Futaki M, Miyake K, Yamada T, Tanabe Y, Ohki I, Dan K, Ozawa K, et al. Inokuchi K, et al. Among authors: futaki m. Blood. 1991 Dec 15;78(12):3125-7. Blood. 1991. PMID: 1742479 Free article.

8

Abnormality of c-kit oncoprotein in certain patients with chronic myelogenous leukemia--potential clinical significance.

Inokuchi K, Yamaguchi H, Tarusawa M, Futaki M, Hanawa H, Tanosaki S, Dan K. Inokuchi K, et al. Among authors: futaki m. Leukemia. 2002 Feb;16(2):170-7. doi: 10.1038/sj.leu.2402341. Leukemia. 2002. PMID: 11840282

9

Minimal residual disease in acute myelogenous leukemia with PML/RAR alpha or AML1/ETO mRNA and phenotypic analysis of possible T and natural killer cells in bone marrow.

Inokuchi K, Iwakiri R, Futaki M, Hanawa H, Tanosaki S, Nomura T, Dan K. Inokuchi K, et al. Among authors: futaki m. Leuk Lymphoma. 1998 May;29(5-6):553-61. doi: 10.3109/10428199809050915. Leuk Lymphoma. 1998. PMID: 9643569

10

Heterogenous expression of bcr-abl fusion mRNA in a patient with Philadelphia-chromosome-positive acute lymphoblastic leukaemia.

Inokuchi K, Futaki M, Hanawa H, Tanosaki S, Yamaguchi H, Iwakiri R, Nomura T, Dan K. Inokuchi K, et al. Among authors: futaki m. Br J Haematol. 1997 Jun;97(4):837-40. doi: 10.1046/j.1365-2141.1997.1452959.x. Br J Haematol. 1997. PMID: 9217185 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters